MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517062324 A) filed by Baylor College Of Medicine; and The United States Of America As Represented By The Department Of Veterans Affairs, Houston, on June 30, for 'bacteriophage compositions and methods for treatment of bacterial infections.'
Inventor(s) include Maresso, Anthony; Green, Sabrina; Terwilliger, Austen; Ramig, Robert; Salazar, Keiko; Clark, Justin R.; and Trautner, Barbara.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "Disclosed are compositions, devices, kits, and methods for treatment of Enterobacteriaceae infection. Aspects of the present disclosure are directed to bacteriophage compositions comprising one or more of ES17, ES19, HP3, HP3.1, and HP3.2. Certain aspects of the disclosure are directed to compositions comprising (a) bacteriophage ES17 or bacteriophage ES19, (b) bacteriophage HP3, and (c) bacteriophage HP3.1. Also disclosed are compositions comprising bacteriophage HP 3.2. Further disclosed are devices and kits comprising such compositions and methods for use of such compositions in treatment and prevention of pathogenic E. coli infection."
The patent application was internationally filed on Dec. 05, 2022, under International application No.PCT/US2022/080888.
Disclaimer: Curated by HT Syndication.